Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -269.16% is 56% above its 2-year average of -609.04%, near the high end of its 2-year range (-2193.34%–-117.19%).
As of the fiscal period ended Tuesday, June 30, 2026. 69.42% above its 12-month average of -880.13%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -269.16%.
RETURN ON INVESTED CAPITAL (ROIC)
-269.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-880.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+69.42%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-655.11%
vs the sector median at left
Medicus Pharma Ltd. Common Stock
Market Cap
$10.10M
Return on Invested Capital (ROIC)
-269.16%
TTM Avg
-880.13%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.18M
Return on Invested Capital (ROIC)
-323.71%
TTM Avg
-133.57%
3Y Avg
-246.04%
5Y Avg
-170.10%
Market Cap
$9.98M
Return on Invested Capital (ROIC)
-55.13%
TTM Avg
-99.85%
3Y Avg
-167.97%
5Y Avg
-308.25%
Market Cap
$9.97M
Return on Invested Capital (ROIC)
-227.67%
TTM Avg
-121.58%
3Y Avg
-92.03%
5Y Avg
-78.85%
Market Cap
$9.92M
Return on Invested Capital (ROIC)
-59.35%
TTM Avg
-68.11%
3Y Avg
-104.39%
5Y Avg
-133.77%
Market Cap
$9.79M
Return on Invested Capital (ROIC)
-80.51%
TTM Avg
-60.18%
3Y Avg
-50.63%
5Y Avg
-247.68%
Market Cap
$11.13M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-47.37%
3Y Avg
-38.90%
5Y Avg
-35.62%
Market Cap
$10.52M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-27.20%
3Y Avg
-100.49%
5Y Avg
-187.87%
Market Cap
$9.66M
Return on Invested Capital (ROIC)
-183.45%
TTM Avg
-213.20%
3Y Avg
-179.79%
5Y Avg
-169.02%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medicus Pharma Ltd. Common Stock (MDCX) | $10.10M | -269.16% | -880.13% | N/A | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.18M | -323.71% | -133.57% | -246.04% | -170.10% |
| Valion Bio, Inc. (VBIO)vs › | $9.98M | -55.13% | -99.85% | -167.97% | -308.25% |
| Senti Biosciences, Inc. (SNTI)vs › | $9.97M | -227.67% | -121.58% | -92.03% | -78.85% |
| Satellos Bioscience Inc. (MSLE)vs › | $9.92M | -59.35% | -68.11% | -104.39% | -133.77% |
| Ainos, Inc. (AIMD)vs › | $9.79M | -80.51% | -60.18% | -50.63% | -247.68% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.13M | N/A | -47.37% | -38.90% | -35.62% |
| Polyrizon Ltd. (PLRZ)vs › | $10.52M | N/A | -27.20% | -100.49% | -187.87% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.66M | -183.45% | -213.20% | -179.79% | -169.02% |
| MetaVia Inc. (MTVA)vs › | $9.62M | -215.61% | -191.09% | -141.72% | -179.96% |
ROIC
-269.2%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -269.16% |
| 2026-03-31 | -2193.34% |
| 2025-12-31 | -854.10% |
| 2025-06-30 | -203.93% |
| 2025-03-31 | -625.54% |
| 2024-12-31 | -323.43% |
| 2024-09-30 | -285.67% |
| 2024-06-30 | -117.19% |
